拉特克裂囊:从历史到分子遗传学
Aysa Hacioglu1, Halil Tekiner2, Meric A Altinoz3
1Department of Endocrinology, Erciyes University, Kayseri, Turkey.
Reviews in endocrine & metabolic disorders
|February 12, 2025
概括
拉特克裂囊 (RCC) 是一种常见的垂体病变. 新的分子标记物和诊断方法有助于区分RCC与喉瘤,引导治疗从观察到手术或放射性手术.
科学领域:
- 神经内分泌学神经内分泌学
- 下垂体病理学 下垂体病理学
- 发展生物学 发展生物学
背景情况:
- 拉特克裂囊 (RCC) 是一种常见的良性垂体病变,起源于拉特克囊残留物.
- 它们可以呈现无症状或具有渐进的症状,通常在脑部成像上偶然发现.
- 准确的差异诊断,特别是排除喉瘤,至关重要.
研究的目的:
- 审查拉特克裂囊的发病,诊断和管理.
- 突出新型分子标记物和RCCs的诊断工具.
- 根据临床表现讨论当前的治疗策略.
主要方法:
- 关于拉特克裂囊病原和诊断的最新文献的综述.
- 分析分子机制,包括PROP-1和白血病抑制因子.
- 评估免疫组织化学标记物 (细胞素8和2) 和β-catenin突变,用于差异诊断.
主要成果:
- 高PROP-1表达和白血病抑制因子与RCC病变发生有关.
- 细胞激素8和2的表达有助于区分RCC与骨瘤.
- β-catenin突变在喉瘤中发现,但通常不在RCC中.
结论:
- 了解分子发病因子有助于RCC诊断和管理.
- 观察适用于小,无症状的RCC;手术适用于有症状的病例.
- 在低风险的复发性RCC中,立体射线手术是有效的.
更多相关视频
10:13Multi-Photon Time Lapse Imaging to Visualize Development in Real-time: Visualization of Migrating Neural Crest Cells in Zebrafish Embryos
Published on: August 9, 2017
7.6K
09:55Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts
Published on: May 16, 2020
3.8K
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
